COVID-19 Medicine Update

COVID-19 Medicine Update: Restricted Emergency Use authorizations (EUA) for Medications in India

COVID-19 Medication, Drug Approvals, Medicinal Product Updates, Pharmacovigilance, Voluntary ADR reporting, , , , , , ,

The national regulatory body for Indian pharmaceuticals and medical devices- Central Drugs Standard Control Organisation (CDSCO) has provided approval as part of restricted & emergency use authorization for the below two medicines considering the unmet medical need for treatment of COVID-19 infected patients- Favipiravir Tablets for mild to moderate COVID-19 infection subject to various conditions…

Read More

Highlights of Remdesivir (A potential treatment for COVID-19?)

COVID-19 Medication, Drug Safety Updates, Pharmacovigilance, , , , , , , ,

Remdesivir (GS-5734) is being developed by Gilead Sciences, an American biopharmaceutical company based in California with a primary therapeutic focus in antiviral medicines. Remdesivir is an antiviral drug (broad spectrum) under clinical trial investigation for the treatment of COVID-19 (coronavirus disease). Remdesivir gained public attention due to publication of some of its clinical study results…

Read More

error: Content is protected !!